Type 2 Diabetes Mellitus

Showing 1 - 25 of 1,595

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Multiple Dose Insulin Therapy
  • Personalized treatment
  • (no location specified)
Nov 18, 2023

Type 2 Diabetes Trial in Seoul (SGLT2 inhibitor)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • SGLT2 inhibitor
  • Seoul, Seodaemun-gu, Korea, Republic of
    Severance Hospital
Nov 17, 2023

Type 2 Diabetes Trial (Acetaminophen/SHR20004, Acetaminophen/Placebo)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • (no location specified)
Nov 17, 2023

Healthy, Type 2 Diabetes Trial in United States (LY3938577, Placebo, Insulin degludec)

Not yet recruiting
  • Healthy
  • Type 2 Diabetes Mellitus
  • Anaheim, California
  • +3 more
Nov 10, 2023

Harmonizing RCT-Duplicate Emulations In A Real World Replication

Completed
  • Type 2 Diabetes Mellitus
  • Gothenburg, Sweden
    Research Site
Oct 23, 2023

Type 2 Diabetes, Mild Cognitive Impairment Trial in Nanjing (Henagliflozin, Gliclazide)

Recruiting
  • Type 2 Diabetes Mellitus
  • Mild Cognitive Impairment
  • Nanjing, Jiangsu, China
    Division of Endocrinology, the Affiliated Drum Tower Hospital of
Oct 10, 2023

Type 2 Diabetes Trial in Beijing (HSK7653, Metformin)

Completed
  • Type 2 Diabetes Mellitus
  • Beijing, Beijing, China
    Peking University Third Hospital
Oct 10, 2023

Type 2 Diabetes, Lipid Metabolism Disorder, Fatty Acid Metabolism Disorder Trial in Lianshui (omega-3 polyunsaturated fatty

Completed
  • Type 2 Diabetes Mellitus
  • +2 more
  • omega-3 polyunsaturated fatty acids
  • corn oil
  • Lianshui, Jiangsu, China
    Lian Shui People's Hospital
Oct 2, 2023

Type 2 Diabetes Trial in Worldwide (Cagrilintide, Semaglutide, Placebo cagrilintide)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Birmingham, Alabama
  • +331 more
Sep 26, 2023

Type 2 Diabetes Trial in Beijing (HSK7653 10 mg, HSK7653 25 mg, HSK7653 50 mg)

Completed
  • Type 2 Diabetes Mellitus
  • HSK7653 10 mg
  • +3 more
  • Beijing, Beijing, China
    Peking university people's hospital
Sep 23, 2023

Type 2 Diabetes, Hypertension Trial in Lexington (Fresh Funds)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Hypertension
  • Fresh Funds
  • Lexington, Kentucky
    University of Kentucky
Sep 5, 2023

Type 2 Diabetes, Hypertension Trial in Ibadan (Educational intervention)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Hypertension
  • Educational intervention
  • Ibadan, Oyo, Nigeria
    Department of Clinical Pharmacy and Pharmacy Administration, Fac
Aug 14, 2023

Remission WithVery Low-calorie Ketogenic Diet and Lifestyle

Recruiting
  • Type 2 Diabetes Mellitus
  • Overweight and Obesity
  • VLCKD
  • Lausanne, Switzerland
    Dr. Daniela Sofra
Aug 2, 2023

Gestational Diabetes in Pregnancy, Type 2 Diabetes Trial in Lexington, Louisville (Fresh Funds for Mom's, Standard Medical care,

Not yet recruiting
  • Gestational Diabetes Mellitus in Pregnancy
  • Type 2 Diabetes Mellitus
  • Fresh Funds for Mom's
  • +2 more
  • Lexington, Kentucky
  • +1 more
Jul 28, 2023

A Study of Glycemic Control in Left Ventricular Assist

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • +2 more
  • Freestyle Libre 3 Continuous Glucose Monitor (CGM)
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 28, 2023

Type 2 Diabetes, Gaming, Motivational Interviewing Trial in Bingöl (Patient Education with Game-Based Mobile Technology and

Completed
  • Type 2 Diabetes Mellitus
  • +5 more
  • Patient Education with Game-Based Mobile Technology and Motivational Interviewing
  • Bingöl, Centrer, Turkey
    Bingol State Hospital
Jun 24, 2023

Type 2 Diabetes Trial in Hortolândia (LID104, Dapagliflozin, Linagliptin)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Hortolândia, SP, Brazil
    Investigational site
May 23, 2023

Rate and Risk Signature in Semirural Sub-Saharan Africa

Not yet recruiting
  • Chronic Kidney Diseases
  • +6 more
    • Bagamoyo, Pwani, Tanzania
      Bagamoyo District Hospital
    May 19, 2023

    The Impact of Frailty in Type 2 Diabetes

    Enrolling by invitation
    • Type 2 Diabetes Mellitus
    • arms
    • Kırıkkale, Merkez, Turkey
      Gulsah Turanoglu
    May 8, 2023

    Type 1 Diabetes, Type 2 Diabetes, Hyperglycemia Trial in Winston-Salem (Libre 2.0 CGM in patients taking subcutaneous insulin

    Not yet recruiting
    • Type 1 Diabetes Mellitus
    • +2 more
    • Libre 2.0 CGM in patients taking subcutaneous insulin with concomitant high dose glucocorticoids
    • Winston-Salem, North Carolina
      WakeForest University Health Sciences
    May 11, 2023

    Type 2 Diabetes Trial in Nanjing (Mulberry Twig Alkaloid Tablet, Canagliflozin)

    Active, not recruiting
    • Type 2 Diabetes Mellitus
    • Nanjing, China
      Jianhua Ma
    May 3, 2023

    Type 2 Diabetes Trial (Food-related inhibitory control training based on computer, Non-food-related inhibitory control training

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • Food-related inhibitory control training based on computer
    • Non-food-related inhibitory control training based on computer
    • (no location specified)
    Apr 22, 2023

    Type 2 Diabetes Trial in Seoul (Treatment Period(JW0201), Treatment Period(Placebo), Extension Period(JW0201))

    Recruiting
    • Type 2 Diabetes Mellitus
    • Treatment Period(JW0201)
    • +2 more
    • Seoul, Korea, Republic of
      Kangbuk Samsung Hospital
    Apr 3, 2023

    Type 2 Diabetes Trial in Gwangju (JW0201, Placebo)

    Recruiting
    • Type 2 Diabetes Mellitus
    • Gwangju, Korea, Republic of
      Chosun University Hospital
    Apr 3, 2023

    Oral Health Policy for Type 2 Diabetes Mellitus in Chile: A

    Enrolling by invitation
    • Type 2 Diabetes Mellitus
    • +3 more
    • Periodontal treatment
    • Puerto Varas, De Los Rios, Chile
    • +1 more
    Apr 11, 2023